PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Laboratory Corporation of America Holdings (LH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS50540R4092
CUSIP50540R409
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$18.37B
EPS$4.33
PE Ratio50.45
PEG Ratio0.51
Revenue (TTM)$12.16B
Gross Profit (TTM)$4.39B
EBITDA (TTM)$1.62B
Year Range$177.78 - $233.32
Target Price$246.80
Short %3.21%
Short Ratio2.23

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Laboratory Corporation of America Holdings

Popular comparisons: LH vs. CAH, LH vs. RDNT, LH vs. SPY, LH vs. COST, LH vs. ONEQ, LH vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Laboratory Corporation of America Holdings, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


1,000.00%1,200.00%1,400.00%1,600.00%1,800.00%NovemberDecember2024FebruaryMarchApril
1,073.66%
1,747.90%
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

S&P 500

Returns By Period

Laboratory Corporation of America Holdings had a return of -11.73% year-to-date (YTD) and 2.46% in the last 12 months. Over the past 10 years, Laboratory Corporation of America Holdings had an annualized return of 8.96%, while the S&P 500 had an annualized return of 10.43%, indicating that Laboratory Corporation of America Holdings did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-11.73%5.29%
1 month-4.57%-2.47%
6 months-0.21%16.40%
1 year2.46%20.88%
5 years (annualized)10.47%11.60%
10 years (annualized)8.96%10.43%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-2.20%-2.59%1.22%
2023-3.39%-0.66%8.98%4.79%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LH is 52, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of LH is 5252
Laboratory Corporation of America Holdings(LH)
The Sharpe Ratio Rank of LH is 5555Sharpe Ratio Rank
The Sortino Ratio Rank of LH is 4646Sortino Ratio Rank
The Omega Ratio Rank of LH is 4646Omega Ratio Rank
The Calmar Ratio Rank of LH is 5555Calmar Ratio Rank
The Martin Ratio Rank of LH is 5656Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


LH
Sharpe ratio
The chart of Sharpe ratio for LH, currently valued at 0.11, compared to the broader market-2.00-1.000.001.002.003.000.11
Sortino ratio
The chart of Sortino ratio for LH, currently valued at 0.27, compared to the broader market-4.00-2.000.002.004.000.27
Omega ratio
The chart of Omega ratio for LH, currently valued at 1.03, compared to the broader market0.501.001.501.03
Calmar ratio
The chart of Calmar ratio for LH, currently valued at 0.06, compared to the broader market0.001.002.003.004.005.000.06
Martin ratio
The chart of Martin ratio for LH, currently valued at 0.33, compared to the broader market0.0010.0020.0030.000.33
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.79, compared to the broader market-2.00-1.000.001.002.003.001.79
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.61, compared to the broader market-4.00-2.000.002.004.002.61
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.001.002.003.004.005.001.36
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current Laboratory Corporation of America Holdings Sharpe ratio is 0.11. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
0.11
1.79
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

Dividends

Dividend History

Laboratory Corporation of America Holdings granted a 1.39% dividend yield in the last twelve months. The annual payout for that period amounted to $2.78 per share.


PeriodTTM20232022
Dividend$2.78$2.68$1.86

Dividend yield

1.39%1.18%0.92%

Monthly Dividends

The table displays the monthly dividend distributions for Laboratory Corporation of America Holdings. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.72$0.00
2023$0.00$0.62$0.00$0.00$0.62$0.00$0.00$0.72$0.00$0.00$0.72$0.00
2022$0.62$0.00$0.00$0.62$0.00$0.00$0.62$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%1.4%
Laboratory Corporation of America Holdings has a dividend yield of 1.39%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%19.4%
Laboratory Corporation of America Holdings has a payout ratio of 19.43%, which is below the market average. This means Laboratory Corporation of America Holdings returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-24.05%
-4.42%
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Laboratory Corporation of America Holdings. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Laboratory Corporation of America Holdings was 96.05%, occurring on Aug 31, 1998. Recovery took 2078 trading sessions.

The current Laboratory Corporation of America Holdings drawdown is 24.05%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.05%Dec 31, 19911686Aug 31, 19982078Dec 4, 20063764
-46.58%Feb 18, 202025Mar 23, 202082Jul 20, 2020107
-44.38%Jul 23, 1990117Jan 7, 199154Mar 25, 1991171
-36.21%Jun 18, 2018132Dec 24, 2018286Feb 13, 2020418
-34.61%Jan 3, 2022195Oct 11, 2022

Volatility

Volatility Chart

The current Laboratory Corporation of America Holdings volatility is 4.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%NovemberDecember2024FebruaryMarchApril
4.00%
3.35%
LH (Laboratory Corporation of America Holdings)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Laboratory Corporation of America Holdings over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items